Home » Topics » Regulatory » Patents

Patents
RSS

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

Macrolactine M described by Ocean Biotechnology

March 12, 1998

Cephalon reports K-252a derivatives for neurology indications

March 12, 1998

Vasopressin antagonists for treating CHF

March 12, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...